SCHEMBL15315643

SCHEMBL15315643

c1ccc2c(c1)sc1cc(-c3nc(-c4ccc5c(c4)sc4ccccc45)nc(-c4ccc5c(c4)sc4ccccc45)n3)ccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.54
MAPT P10636 4/20 0.53
ALDH1A1 P00352 4/20 0.53
HPGD P15428 2/20 0.53
RAB9A P51151 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
APP P05067 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALOX5 P09917 1/20 0.38
CYP1A2 P05177 1/20 0.37
ATM Q13315 1/20 0.37
PIK3CD O00329 1/20 0.37
PIP5K1C O60331 1/20 0.37
PI4KA P42356 1/20 0.37
PIK3CG P48736 1/20 0.37
PI4KB Q9UBF8 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MMP9 P14780 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30422699 1.00 GPR3 (0.54) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL25068704 0.95 MAPT (0.49) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL21116797 0.95 MAPT (0.49) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL21109846 0.95 MAPT (0.49) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL21707322 0.95 MAPT (0.49) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL21116914 0.95 MAPT (0.49) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL14733827 0.95 MAPT (0.49) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL21974026 0.93 MAPT (0.47) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL22240647 0.93 MAPT (0.47) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL21109793 0.93 MAPT (0.47) GPR3MAPTALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10944061-B2 Organic electroluminescent element and compound UDC IRELAND LIMITED (IE) 2021-03-09 US disclosed
US-20190198780-A1 ORGANIC COMPOUND AND COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-06-27 US disclosed
US-20130270530-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND COMPOUND UDC IRELAND LIMITED (IE) 2013-10-17 US disclosed
US-20130270530-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND COMPOUND UDC IRELAND LIMITED (IE) 2013-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10944061-B2 Organic electroluminescent element and compound POU2F2, DDT, LEF1 GPR3 4533/4885MAPT 713/4885ALDH1A1 1094/4885
US-20190198780-A1 ORGANIC COMPOUND AND COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OR51E2 GPR3 209/4885MAPT 2200/4885ALDH1A1 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.